For this pharmacological property they are considered the treatment of choice for Paget's
disease of bone, malignant hypercalcaemia, bone metastases, and several forms of …

A small number of reports of suspected adverse reactions to bisphosphonates describe eye
disorders including uveitis (13 reports), iritis (6), scleritis/episcleritis (7), haemorrhage (4) …

A 62-year-old man was referred for left eye redness and pain from the emergency
department. He had a medical history of metastatic castrate-sensitive prostate cancer …

Discussion Cases of ocular inflammation in patients taking bisphosphonates have been
reported since the early 1990s. 5, 6 Cases have involved both nitrogen and non-nitrogen …

Biphosphonates are increasingly being used for the prevention and treatment of
osteoporosis in women where hormone replacement therapy is contraindicated. 1, 2 …

Bisphosphonate infusions are associated with adverse events in approximately a third of
patients. Ocular complications are rare and even more so, inflammatory orbital disease …

Background/Aims: To highlight the potential ocular side effects of bisphosphonate therapy
and the importance of a proper drug history in patients who present with uveitis. Methods …

Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …

Adverse ocular effects related to bisphosphonates, the most common treatment for
osteoporosis, are well established, including anterior uveitis, scleritis, episcleritis, and …

Bisphosphonates are used to inhibit bone absorption as a treatment for hypercalcemia
associated with osteolytic bone cancer, bony metastasis, Paget disease, and osteoporosis …